CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹386 Cr | ₹306 Cr | ₹331 Cr | ₹268 Cr | ₹208 Cr |
What is the latest Total Current Liabilities ratio of CAPLIN POINT LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹386 Cr |
| Mar2025 | ₹306 Cr |
| Mar2024 | ₹331 Cr |
| Mar2023 | ₹268 Cr |
| Mar2022 | ₹208 Cr |
How is Total Current Liabilities of CAPLIN POINT LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹386 Cr | 26.13 | |
| Mar2025 | ₹306 Cr | -7.51 | |
| Mar2024 | ₹331 Cr | 23.45 | |
| Mar2023 | ₹268 Cr | 29.04 | |
| Mar2022 | ₹208 Cr | - | |
Compare Total Current Liabilities of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹18,617.7 Cr | 3.7% | -4% | 18.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | 3.7% |
-4% |
18.7% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses